Elastin Bioscience at the BIO CEO and Investor Conference, New York

Ivan Morgunov, founder of Longaevus Technologies; Sherif Idriss, CEO of Elastin Biosciences (Longaevus’ spin-off) at the BIO CEO & Investor Conference 2024 in New York.

The BIO CEO & Investor Conference stands as a prominent fixture within the biotech industry, drawing together institutional investors, industry analysts, and senior executives to collectively influence the future investment trajectory of biotechnology. At this esteemed event, our team effectively showcased our groundbreaking advancements in elastin rejuvenation, garnering significant interest and establishing valuable new connections within the industry.